levofloxacin has been researched along with Liver Dysfunction in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alba, L; Behta, M; Clock, SA; Della-Latta, P; Furuya, EY; Jenkins, SG; Jia, H; Kubin, CJ; Oliveira, AP; Patel, SJ; Rhee, K; Saiman, L; Schuetz, AN; Weisenberg, SA; Whittier, S; Zhou, JJ | 1 |
Blomme, EA; Ditewig, AC; Ganey, PE; Liguori, MJ; Roth, RA; Shaw, PJ; Waring, JF | 1 |
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Tang, HJ; Toh, HS; Wang, JH; Yu, KW | 1 |
Coker, A; Coker, C; Erkan, N; Onek, T; Sağol, O; Zeytunlu, M | 1 |
Ascione, T; Esposito, S; Gaeta, GB; Ianniello, F; Leone, S; Noviello, S | 1 |
Kawai, H; Komiya, M; Matsumoto, T; Nakayasu, T; Shimada, J; Yamaguchi, H; Yokoyama, H | 1 |
Ahmed, S; Karim, A; Rossoff, LJ; Siddiqui, RK; Steinberg, HN | 1 |
7 other study(ies) available for levofloxacin and Liver Dysfunction
Article | Year |
---|---|
Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units.
Topics: Acinetobacter Infections; Adolescent; Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Immunocompromised Host; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Liver Diseases; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Time Factors | 2014 |
Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injury.
Topics: Analysis of Variance; Animals; Chemical and Drug Induced Liver Injury; Female; Fluoroquinolones; Gene Expression; Hepatocytes; Inflammation; Interferon-gamma; Interleukin-18; Janus Kinases; Levofloxacin; Lipopolysaccharides; Liver; Liver Diseases; Male; Mice; Mice, Inbred BALB C; Naphthyridines; Necrosis; Ofloxacin; Oligonucleotide Array Sequence Analysis; STAT Transcription Factors; Transcriptional Activation | 2009 |
Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gallbladder Diseases; Hospitalization; Humans; Levofloxacin; Liver Diseases; Microbial Sensitivity Tests; Ofloxacin; Population Surveillance; Practice Guidelines as Topic; Prevalence; Prospective Studies; Pseudomonas aeruginosa; Taiwan; Time Factors | 2012 |
Effects of selected antibiotics on pancreatitis induced liver and pulmonary injury.
Topics: Acute Disease; Alanine Transaminase; Amylases; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Imipenem; L-Lactate Dehydrogenase; Levofloxacin; Liver; Liver Diseases; Lung; Lung Diseases; Male; Nitric Oxide; Ofloxacin; Pancreatitis; Rats; Rats, Wistar | 2005 |
Clinical efficacy and tolerability of levofloxacin in patients with liver disease: a prospective, non comparative, observational study.
Topics: Administration, Oral; Anti-Bacterial Agents; Chronic Disease; Drug Tolerance; Female; Humans; Levofloxacin; Liver Diseases; Male; Middle Aged; Ofloxacin; Peritonitis; Pneumonia; Prospective Studies; Urinary Tract Infections | 2006 |
Post-marketing surveillance of the safety of levofloxacin in Japan.
Topics: Achilles Tendon; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Chemical and Drug Induced Liver Injury; Female; Humans; Hypoglycemia; Japan; Levofloxacin; Liver Diseases; Long QT Syndrome; Male; Middle Aged; Ofloxacin; Photosensitivity Disorders; Product Surveillance, Postmarketing; Seizures; Torsades de Pointes | 2007 |
Possible levofloxacin-induced acute hepatocellular injury in a patient with chronic obstructive lung disease.
Topics: Acute Disease; Aged; Anti-Infective Agents; Chemical and Drug Induced Liver Injury; Female; Humans; Infusions, Intravenous; Levofloxacin; Liver; Liver Diseases; Liver Function Tests; Ofloxacin; Pulmonary Disease, Chronic Obstructive | 2001 |